Hestia Insight Inc. (HSTA) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Hestia Insight Inc. (HSTA) es una empresa del sector Technology valorada en 0. Calificado con 39/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Perfil Tecnológico y Posición Competitiva de Hestia Insight Inc. (HSTA)
Hestia Insight Inc. provides strategic consulting and capital market advisory services, primarily targeting micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors. Additionally, they offer healthcare management, technology development, and sales support, positioning them as a multifaceted service provider in specialized markets.
Tesis de Inversión
Hestia Insight Inc. presents a unique investment proposition as a consulting and advisory firm operating at the intersection of healthcare, biotech, and fintech. The company's focus on micro, small, and medium-sized businesses allows it to cater to a niche market often underserved by larger consulting firms. Key value drivers include the potential for revenue growth through expansion of its service offerings and client base within its target sectors. However, investors may want to evaluate the risks associated with the company's small size, limited resources, and dependence on key personnel. The company's P/E ratio is -0.78 and Beta is -0.31 as of March 16, 2026.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Hestia Insight Inc. operates with a small team of 3 employees, indicating a lean operational structure.
- The company's focus on micro, small, and medium-sized businesses in healthcare, biotech, and fintech allows for specialized service offerings.
- Hestia Insight provides a diverse range of services, including strategic consulting, capital market advisory, healthcare management, and technology development.
- The company's negative P/E ratio of -0.78 suggests that it is currently not profitable.
- The company's beta of -0.31 indicates a low correlation with the overall market, potentially offering some downside protection.
Competidores y Pares
Fortalezas
- Specialized focus on healthcare, biotech, and fintech sectors.
- Integrated service offerings covering consulting, advisory, and technology development.
- Agile and responsive due to small company size.
- Established presence in Las Vegas.
Debilidades
- Limited financial resources and capital.
- High dependence on key personnel.
- Small team size may limit scalability.
- OTC market listing may reduce investor confidence.
Catalizadores
- Upcoming: Potential partnerships with fintech companies to expand service offerings in the fintech sector.
- Ongoing: Increasing demand for healthcare technology solutions for neurological and psychiatric disorders.
- Ongoing: Expansion of healthcare management services to address the needs of micro and small healthcare providers.
Riesgos
- Potential: Limited financial resources may constrain growth initiatives and expansion plans.
- Potential: Dependence on key personnel could disrupt operations if they leave the company.
- Ongoing: Intense competition from larger consulting firms with greater resources and brand recognition.
- Potential: Evolving regulatory landscape in healthcare and fintech may require costly compliance efforts.
- Ongoing: OTC market listing may reduce investor confidence and limit access to capital.
Oportunidades de crecimiento
- Expansion of Healthcare Technology Development: Hestia Insight can capitalize on the growing demand for innovative healthcare technologies by expanding its development capabilities. The global healthcare technology market is projected to reach $280 billion by 2028, presenting a significant opportunity for Hestia Insight to develop and commercialize new solutions for neurological and psychiatric disorders. Timeline: 2-3 years.
- Strategic Partnerships with Fintech Companies: Collaborating with emerging fintech companies to provide specialized consulting services can drive growth. The fintech market is experiencing rapid growth, with a projected market size of $509 billion by 2029. Hestia Insight can leverage its expertise in capital markets and healthcare to offer valuable insights to fintech companies seeking to disrupt the healthcare industry. Timeline: 1-2 years.
- Increased Focus on Healthcare Management Services: The demand for efficient healthcare management services is increasing as healthcare providers seek to optimize operations and improve patient outcomes. Hestia Insight can expand its healthcare management offerings to address this need, targeting micro and small healthcare providers that may lack the resources to implement sophisticated management systems. Timeline: Ongoing.
- Geographic Expansion Beyond Las Vegas: Hestia Insight can explore opportunities to expand its geographic reach beyond Las Vegas, targeting other regions with a high concentration of healthcare, biotech, and fintech companies. This expansion can be achieved through strategic partnerships, remote service delivery, and the establishment of satellite offices. Timeline: 3-5 years.
- Development of Proprietary Healthcare Analytics Platform: Creating a proprietary healthcare analytics platform can provide Hestia Insight with a competitive advantage and generate recurring revenue streams. This platform can leverage data analytics and machine learning to provide insights into patient behavior, treatment outcomes, and market trends, enabling healthcare providers to make more informed decisions. Timeline: 2-3 years.
Oportunidades
- Expansion into new geographic markets.
- Development of proprietary healthcare technology solutions.
- Strategic partnerships with complementary businesses.
- Increased demand for specialized consulting services in target sectors.
Amenazas
- Intense competition from larger consulting firms.
- Evolving regulatory landscape in healthcare and fintech.
- Economic downturn impacting client spending.
- Technological disruptions rendering existing services obsolete.
Ventajas competitivas
- Specialized expertise in the intersection of healthcare, biotech, and fintech.
- Focus on micro, small, and medium-sized businesses, a niche often underserved by larger firms.
- Integrated service offerings spanning consulting, advisory, technology development, and sales support.
Acerca de HSTA
Hestia Insight Inc., formerly known as Luxshmi Investments, Inc. until its name change in May 2019, is a Las Vegas-based firm providing strategic consulting and capital market advisory services. The company focuses on serving micro, small, and medium-sized enterprises within the healthcare, biotech, and fintech sectors. Hestia Insight offers a range of services, including healthcare management and patient services, development of healthcare technologies and analysis for neurological and psychiatric disorders, and medical supply sales support and management. The company also provides sales and marketing guidance to its clients. Hestia Insight's multifaceted approach aims to support its clients through various stages of growth and development, leveraging its expertise in both the financial and healthcare technology domains. The company operates with a small team of three employees.
Qué hacen
- Provides strategic consulting services to micro, small, and medium-sized companies.
- Offers capital market advisory services.
- Delivers healthcare management and patient services.
- Develops healthcare technologies and analysis for neurological and psychiatric disorders.
- Provides medical supply sales support and management.
- Offers sales and marketing guidance and services.
Modelo de Negocio
- Generates revenue through consulting fees for strategic advisory services.
- Earns fees from capital market advisory services, such as assisting with fundraising and M&A transactions.
- Derives income from healthcare management and patient service contracts.
- Potentially generates revenue from the licensing or sale of developed healthcare technologies.
Contexto de la Industria
Hestia Insight Inc. operates within the competitive landscape of consulting and advisory services, specifically targeting the healthcare, biotech, and fintech sectors. These sectors are characterized by rapid innovation, evolving regulatory environments, and significant capital flows. The market for consulting services in these sectors is driven by the need for specialized expertise in areas such as regulatory compliance, technology adoption, and market access. Hestia Insight's focus on micro, small, and medium-sized businesses positions it to capitalize on the demand for tailored solutions in these dynamic industries.
Clientes Clave
- Micro-sized companies in the healthcare sector.
- Small-sized businesses in the biotech industry.
- Medium-sized enterprises in the fintech sector.
Finanzas
Gráfico e información
Precio de la acción de Hestia Insight Inc. (HSTA): Price data unavailable
Últimas noticias
-
Hovde Group Upgrades SouthState Bank (SSB) to Outperform
Yahoo Finance · 25 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para HSTA.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para HSTA.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de HSTA en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Edward C. Lee
Managing Director
Edward C. Lee serves as the Managing Director of Hestia Insight Inc., overseeing a small team of three employees. Information regarding his detailed career history, education, and previous roles is not available. His leadership is pivotal in guiding the strategic direction and operational activities of the company, particularly in the areas of consulting and capital market advisory services.
Historial: Due to limited information available, Edward C. Lee's specific achievements and strategic decisions at Hestia Insight Inc. cannot be comprehensively assessed. However, under his leadership since May 2019, the company has focused on providing services to micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors.
Información del mercado OTC de HSTA
The OTC Other tier represents the lowest tier of the OTC market, indicating that Hestia Insight Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, potentially leading to less transparency and greater volatility.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases information asymmetry and investment risk.
- Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Lack of regulatory oversight increases the potential for fraud and manipulation.
- OTC Other companies may have a higher risk of delisting or going out of business.
- Limited analyst coverage and institutional interest can result in less price discovery and valuation uncertainty.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures, if any.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the company's capital structure and ownership.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Company's incorporation date and history.
- Physical business address and contact information.
- Presence of a functional website and online presence.
- Industry affiliations and memberships.
- Positive client testimonials or case studies (if available).
Preguntas Comunes Sobre HSTA
¿Cuáles son los factores clave para evaluar HSTA?
Hestia Insight Inc. (HSTA) actualmente tiene una puntuación IA de 39/100, indicando puntuación baja. Fortaleza clave: Specialized focus on healthcare, biotech, and fintech sectors.. Riesgo principal a monitorear: Potential: Limited financial resources may constrain growth initiatives and expansion plans.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de HSTA?
HSTA actualmente puntúa 39/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de HSTA?
Los precios de HSTA se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre HSTA?
La cobertura de analistas para HSTA incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en HSTA?
Las categorías de riesgo para HSTA incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Limited financial resources may constrain growth initiatives and expansion plans.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de HSTA?
La relación P/E para HSTA compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está HSTA sobrevalorada o infravalorada?
Determinar si Hestia Insight Inc. (HSTA) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de HSTA?
Hestia Insight Inc. (HSTA) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on Hestia Insight Inc. due to its OTC listing and small market capitalization.
- Financial data is limited and may not be fully reliable.
- AI analysis pending, which may provide additional insights.